Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2M Sell
1,138,844
-460,965
-29% -$2.6M ﹤0.01% 3143
2026
Q1
$4.8M Sell
1,599,809
-1,099,696
-41% -$3.18M ﹤0.01% 4118
2025
Q4
$9.42M Buy
2,699,505
+706,396
+35% +$2.57M ﹤0.01% 3349
2025
Q3
$6.06M Buy
1,993,109
+84,270
+4% +$233K ﹤0.01% 3838
2025
Q2
$4.91M Sell
1,908,839
-154,368
-7% -$435K ﹤0.01% 3908
2025
Q1
$5.18M Buy
2,063,207
+1,349,062
+189% +$4.95M ﹤0.01% 3748
2024
Q4
$1.87M Buy
714,145
+667,511
+1,431% +$2.35M ﹤0.01% 4779
2024
Q3
$178K Buy
46,634
+16,390
+54% +$65.2K ﹤0.01% 5959
2024
Q2
$93.2K Sell
30,244
-88,539
-75% -$411K ﹤0.01% 6210
2024
Q1
$675K Buy
118,783
+112,772
+1,876% +$508K ﹤0.01% 4948
2023
Q4
$25.2K Buy
6,011
+11
+0.2% +$20 ﹤0.01% 6953
2023
Q3
$7.92K Hold
6,000
﹤0.01% 7204
2023
Q2
$9.12K Sell
6,000
-12,082
-67% -$19.4K ﹤0.01% 7197
2023
Q1
$31.6K Buy
18,082
+3,934
+28% +$9.52K ﹤0.01% 6758
2022
Q4
$29.7K Buy
14,148
+13,148
+1,315% +$36K ﹤0.01% 7249
2022
Q3
$3K Hold
1,000
﹤0.01% 9507
2022
Q2
$3K Sell
1,000
-1,686
-63% -$8.38K ﹤0.01% 9270
2022
Q1
$22K Sell
2,686
-267
-9% -$2.1K ﹤0.01% 7329
2021
Q4
$24K Sell
2,953
-411
-12% -$4.68K ﹤0.01% 7618
2021
Q3
$39K Buy
+3,364
New +$65.3K ﹤0.01% 6530

Other funds holding ABSI

UBS Group's ABSI Position: Q2 2026 in Review

UBS Group reduced its Absci (ABSI) stake by 29% in Q2 2026, selling an estimated $2.6M and leaving 1,138,844 shares worth $13.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3143.

UBS Group first reported a position in ABSI in Q3 2021 and has held it in 20 quarters since. 198 funds tracked by Wall St. Rank hold ABSI as of Q2 2026.

  • UBS Group held 1,138,844 shares of Absci worth $13.2M as of Q2 2026.
  • UBS Group sold 460,965 Absci shares in Q2 2026, an estimated $2.6M.
  • Absci made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3143 holding.
  • UBS Group first reported a position in Absci in Q3 2021 and has held it in 20 quarters since.
  • 198 funds tracked by Wall St. Rank held Absci as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.